Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human TNF Receptor II ELISA Kit (AC3287)
Cat.#: ASET-1876
Specifications
Description Human TNF Receptor II ELISA Kit allows for the in vitro quantitative determination of human TNF Receptor II concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 4.688 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 7.813-500 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1989 Mouse FGF2 ELISA Kit (AC3400) Quantitative inquiry ASET-1692 Human LECT2 ELISA Kit (AC3103) Quantitative inquiry ASET-2158 Human GDNF ELISA Kit (AC3569) Quantitative inquiry ASET-2431 Estradiol ELISA Kit (AC3842) Quantitative inquiry ASET-1116 Human DCAMKL1 ELISA Kit (AC2527) Quantitative inquiry ASET-1849 Mouse PTN ELISA Kit (AC3260) Quantitative inquiry ASET-1161 Human SYNGR4 ELISA Kit (AC2572) Quantitative inquiry ASET-2318 Human Semaphorin 3A ELISA Kit (AC3729) Quantitative inquiry ASET-1957 Mouse Nmur1 ELISA Kit (AC3368) Quantitative inquiry ASET-2075 Human PROKR2 ELISA Kit (AC3486) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket